Leaderboard

En | De
No articles selected!     View Cart  
You are here: Urology-Nephrology » Neoplasia/BPH 31. July 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 9508  Previews Next
   
   Articles 1 - 20 / 190146  
   
Apalutamide-induced prostate-specific antigen response and its association with clinical outcomes in metastatic castration sensitive prostate cancer (Review).
Mol Clin Oncol
N S, Mv C, Upadhyay A, Sonone P, Dharmadhikari S, Puppalwar G, Khandhedia C, Mane A, Mehta S.
PMID: 42534213 [PubMed - in process]


[(18)F]PSMA-1007 PET-Based Recurrence Site Distribution and Predictors of Metastatic Disease in Patients With Biochemical Recurrence of Prostate Cancer.
Int J Urol
Hatano K, Watabe T, Hirata T, Konishi M, Kanaki T, Tani M, Oka T, Ishizuya Y, Hayashi T, Yamamoto Y, Kato T, Kawashima A, Fujita K, Uemura M, Giesel FL, Nonomura N.
PMID: 42533777 [PubMed - indexed for MEDLINE]


Oncological Outcomes and Prognostic Factors of Platinum-Based Chemotherapy Followed by Avelumab Maintenance Therapy Compared With Platinum-Based Chemotherapy Alone: A Propensity Score-Matched Analysis in a Real-World Population.
Int J Urol
Matsushita Y, Kita Y, Mukai S, Joraku A, Kobayashi I, Daizumoto K, Sano T, Nakanishi S, Watanabe J, Hatakeyama S, Goriki A, Hazama T, Nishiyama N, Mori K, Kitamura H, Kimura T, Matsui Y, Miyake M, Kobayashi T, Inamoto T, Japanese Urological Oncology Group.
PMID: 42533764 [PubMed - indexed for MEDLINE]


Full-Component Chart-Derived Lee Score, Upfront Androgen Receptor Signaling Inhibitor Selection, and Competing Mortality in Metastatic Hormone-Sensitive Prostate Cancer.
Geriatr Gerontol Int
Kurokawa K, Yamamoto S, Higa K, Bamba H, Kanaoka S, Nakamura K.
PMID: 42533722 [PubMed - indexed for MEDLINE]


Challenges of Bone Scintigraphy in Assessment of Osseous Metastases in Prostate Cancer: Why it is Time to Reconsider Role of (1)â¸F-NaF PET/CT.
Mol Imaging Biol
Zirakchian Zadeh M.
PMID: 42533239 [PubMed - as supplied by publisher]


Tumor and Organ Dose Estimates from (177)Lu-PSMA-617 Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: Results from the RESIST-PC Phase 2 Trial.
J Nucl Med
Ells Z, Meyer C, Masri K, Ryhiner M, Sennung D, Kimura K, Mirando D, Tworowska I, Esfandiari R, Allen-Auerbach MS, Lassmann M, Herrmann K, Eiber M, Fendler WP, Delpassand E, Czernin J, Dahlbom M, Calais J.
PMID: 42532646 [PubMed - as supplied by publisher]


Environmental exposome study for prostate cancer in elderly men from Western China: preliminary findings from a case-control study in the WeEndPd cohort.
BMJ Open
Zhou X, He Y, Jin Y, Peng Z, Zeng B, Zhang Z, Wu Y, Wei C, Mo Z, Cheng J, Chen Y, Wang F, Lu G, Tao K, Yang Z, Wu Y, Zhang W, Zhuang C, Guo W, Li G, Liu Y, Huang Y, Gao R, Zhan Y, Zou X, Yang L, Wei Q, Wei X, Qiu S.
PMID: 42532568 [PubMed - indexed for MEDLINE]


[Testicular Germ Cell Tumors and Penile Cancer: Molecular-Based Diagnosis and Treatment].
Aktuelle Urol
Paffenholz P, Heidenreich A, Weiten R.
PMID: 42532107 [PubMed - as supplied by publisher]


Can prostate cancer be diagnosed with near certainty on MRI?
Eur J Radiol
Cummings C, Allen C, Dickinson L, Pendse D, Emberton M, Giganti F, Moore C, Woernle A, Freeman A, Haider A, Kirkham A.
PMID: 42531699 [PubMed - as supplied by publisher]


Assessing Geographic Disparities in the Availability of Renal Cell Carcinoma Clinical Trials in the United States.
JCO Oncol Pract
Zhang G, Fann J, Castro DV, Shah KU, Li X, Abreu de Goes V, Jaime-Casas S, Mercier B, Li YJ, Agarwal R, Dickter S, Dukkipati A, Goud J, Lau L, Lau LM, Lee J, Shah K, Simon R, Swarat E, Zugman M, Moradi A, Hsu J, Dizman N, Nguyen C, Chehrazi-Raffle A, Barragan-Carrillo R, Pal SK.
PMID: 42531525 [PubMed - as supplied by publisher]


Prognostic significance of TOP2A expression in bladder cancer: Systematic review and meta-analysis.
Can Urol Assoc J
Hendri AZ, Robert R, Febriyanto T, Liliana B, Pratama ADM, Oey O.
PMID: 42531453 [PubMed - as supplied by publisher]


Association between time from diagnosis to radical cystectomy and oncologic outcomes in muscle-invasive urothelial carcinoma of the bladder.
Can Urol Assoc J
Kim P, Kaul S, Fleishman A, Perez-Londono A, Kim S, Bellmunt J, Aghdam N, Olumi AF, Chang P, Wagner A, Gershman B.
PMID: 42531446 [PubMed - as supplied by publisher]


Investigation of a prostate cancer radiation response signature in the breast cancer SweBCG91RT randomized trial.
Clin Cancer Res
Zhao SG, Holmberg E, Lundstedt D, Killander F, Niméus E, Sharifi M, Sjöström M, Karlsson P.
PMID: 42531378 [PubMed - as supplied by publisher]


Concurrent Jackstone Calculus and Prostate Cancer: Should They Be Treated Concurrently or Sequentially?
Am J Mens Health
Tian S, Li H, Jiang Y, Wang C, Liu S, Wu F, Ning H.
PMID: 42531155 [PubMed - indexed for MEDLINE]


Patient-Provider Communication and Treatment Decision-Making among Latino Men with Prostate Cancer: A Qualitative Study.
J Racial Ethn Health Disparities
Rodriguez VE, Mendoza-Aguayo B, Rodriguez J, Ramirez CM, Soto D, Unger JB, Abreu AL, Ariani R, Baezconde-Garbanati L, Ballas L, Stern MC.
PMID: 42530811 [PubMed - as supplied by publisher]


Global trends and knowledge structure in robotic-assisted simple prostatectomy research: a bibliometric and visualized analysis.
J Robot Surg
Daniswara RR, Prakasa AE, Rabiansyah MK, Xius SL, Widjaja JB, Ginting MBW, Achmadsyah A, Ananda NF.
PMID: 42530703 [PubMed - indexed for MEDLINE]


The impact of prostate size on outcomes of aquablation: a prospective study.
World J Urol
Perez D, Mamber A, Pasherstnik M, Koulikov D, Natsheh AE, Shenfeld OZ, Kafka IZ, Chertin B.
PMID: 42530631 [PubMed - indexed for MEDLINE]


Kinesins in Bladder Cancer: Integrating Molecular Mechanisms and Treatment Approaches.
Cell Biol Int
Sayed U, Basheer NM, H M, Nayak PP, Shankhyan A, Eshmetov R, Sadikova S, Ataullaev Z.
PMID: 42529891 [PubMed - indexed for MEDLINE]


Mapping therapy-responsive immune ecotypes in clear cell renal cell carcinoma through integrative omics.
Front Immunol
Zhang Z, He L, Chen B, Zhang H.
PMID: 42529102 [PubMed - indexed for MEDLINE]


PSMA-targeted radioligand therapy in advanced prostate cancer: a narrative review of ^177Lu-PSMA, emerging ^225Ac-PSMA strategies, and therapeutic sequencing.
Oncol Rev
Gierulska N, Jankowska N, Kwiatkowska A, Kuchno P, , Szklener K, Ko, Skórzewska M.
PMID: 42529062 [PubMed]


   
   Articles 1 - 20 / 190146    Page 1 of 9508  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1